163 related articles for article (PubMed ID: 32537561)
1. Current and emerging diagnostic tests available for the novel COVID-19 global pandemic.
Mboowa G
AAS Open Res; 2020; 3():8. PubMed ID: 32537561
[TBL] [Abstract][Full Text] [Related]
2. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
[TBL] [Abstract][Full Text] [Related]
3. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
[TBL] [Abstract][Full Text] [Related]
4. Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
Basu A; Zinger T; Inglima K; Woo KM; Atie O; Yurasits L; See B; Aguero-Rosenfeld ME
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32471894
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.
Lee J; Song JU
J Med Virol; 2021 Jul; 93(7):4523-4531. PubMed ID: 33913533
[TBL] [Abstract][Full Text] [Related]
6. Comparison of SARS-CoV-2 virus detection using the Xpert Xpress rapid molecular test on Abbott M2000 Real-Time System: a cross-sectional study.
Hasanah M; Aulia FA; Wardhani P; Aryati
Ann Med Surg (Lond); 2023 Jun; 85(6):2559-2563. PubMed ID: 37363578
[TBL] [Abstract][Full Text] [Related]
7. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
[TBL] [Abstract][Full Text] [Related]
8. Design and Implementation of Improved SARS-CoV-2 Diagnostic Assays To Mitigate the Impact of Genomic Mutations on Target Failure: the Xpert Xpress SARS-CoV-2 Experience.
Burns BL; Moody D; Tu ZJ; Nakitandwe J; Brock JE; Bosler D; Mitchell SL; Loeffelholz MJ; Rhoads DD
Microbiol Spectr; 2022 Dec; 10(6):e0135522. PubMed ID: 36255326
[TBL] [Abstract][Full Text] [Related]
9. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2.
Smithgall MC; Scherberkova I; Whittier S; Green DA
J Clin Virol; 2020 Jul; 128():104428. PubMed ID: 32434706
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of a refurbished shipping container as a transportable laboratory for rapid SARS-CoV-2 diagnostics.
Muhi S; Tayler N; Hoang T; Prestedge J; Lee JYH; Ballard SA; Isles N; Wlodek A; Greenhalgh A; Williamson DA; Howden BP; Stinear TP
Access Microbiol; 2022; 4(4):000346. PubMed ID: 35812709
[TBL] [Abstract][Full Text] [Related]
12. Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2.
Zhen W; Smith E; Manji R; Schron D; Berry GJ
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32332061
[TBL] [Abstract][Full Text] [Related]
13. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
14. Rapid Evaluation of the Xpert
Noble LD; Scott LE; Munir R; Du Plessis M; Steegen K; Hans L; Marokane P; Da Silva P; Stevens WS
Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611325
[TBL] [Abstract][Full Text] [Related]
15. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
Stevenson M; Metry A; Messenger M
Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
[TBL] [Abstract][Full Text] [Related]
16. Clinical Evaluation of BioFire COVID-19 Test, BioFire Respiratory Panel 2.1, and Cepheid Xpert Xpress SARS-CoV-2 Assays for Sample-to-Answer Detection of SARS-CoV-2.
Park J; Kim SY; Lee J; Hong KH
Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672974
[TBL] [Abstract][Full Text] [Related]
17. Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Andreas Deckert AD; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
Scand J Work Environ Health; 2022 Sep; 48(7):588-590. PubMed ID: 36153787
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for sample pooling on the Cepheid GeneXpert® system using the Cepheid Xpert® Xpress SARS-CoV-2 assay.
Becker MG; Taylor T; Kiazyk S; Cabiles DR; Meyers AFA; Sandstrom PA
PLoS One; 2020; 15(11):e0241959. PubMed ID: 33166373
[TBL] [Abstract][Full Text] [Related]
19. Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: An updated review until June 2020.
Nabil A; Uto K; Elshemy MM; Soliman R; Hassan AA; Ebara M; Shiha G
EXCLI J; 2020; 19():992-1016. PubMed ID: 32788913
[TBL] [Abstract][Full Text] [Related]
20. A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV plus test strategy for the diagnosis of influenza-like illnesses.
Davies S; Boller E; Chase J; Beaubrun A; Miller C; Jensen I
J Med Econ; 2024; 27(1):430-441. PubMed ID: 38328858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
